Bullish Case: Continued cancer research collaborations and co-commercialization deal with Tempus indicate potential for increased adoption and revenue growth.


Show historical bullish cases

Bearish Case: Competition in the genomics industry could limit adoption. Legal issues around patent infringements also pose a risk.


Show historical bearish cases

Takeaway: While opportunities for growth exist through cancer research collaborations, Personalis faces risks from competition, regulations, and uncertain study outcomes. Strategic partnerships will be key to continued adoption of NeXT platform. To summarize, Personalis has potential for revenue growth through increased adoption of its NeXT platform, especially from its recent co-commercialization deal with Tempus. However, it faces risks from competition, regulations, and clinical study outcomes. My previous predictions were generally accurate with a continued focus on cancer collaborations, but I've updated the potential growth and risk estimates. The takeaway is that strategic partnerships will be critical for Personalis to differentiate itself and drive further adoption amidst industry challenges.


Show historical takeaways

Potential Outcomes:

1. Successful cancer collaborations increase adoption of NeXT platform, boosting revenue and stock price by 35% (50% probability).

2. Competition limits adoption of Personalis' offerings, stagnating growth and reducing stock by 25% (30% probability).

3. Stricter regulations on data usage reduce Personalis' capabilities, decreasing stock 15% (20% probability).


December 06, 2023


Personalis Forecast

[PSNL]  Personalis
Price Forecast: BEARISH    Price Action: MEAN REVERTING (?)



Make More Profitable Trades with PSNL Forecasts + Trading Strategies







PSNL Balanced News:










Become a more profitable trader with AI optimized trading strategies




Correlated Stock Forecasts

Assets that tend to move strongly with PSNL



LCID Forecast + Options Trading Strategies   [LCID]  Lucid (0.89)


FVRR Forecast + Options Trading Strategies   [FVRR]  Fiverr (0.89)


AA Forecast + Options Trading Strategies   [AA]  Alcoa (0.88)


DDD Forecast + Options Trading Strategies   [DDD]  3D Systems (0.88)


FL Forecast + Options Trading Strategies   [FL]  Foot Locker (0.88)



Uncorrelated Stock Forecasts

Assets with little price relationship to PSNL



WGO Forecast + Options Trading Strategies   [WGO]  Winnebago Industries (-0.0)


MSOS Forecast + Options Trading Strategies   [MSOS]  Advisorshares Trust - AdvisorShares Pure US Cannabis (-0.01)


LDOS Forecast + Options Trading Strategies   [LDOS]  Leidos (0.01)


DHT Forecast + Options Trading Strategies   [DHT]  DHT (0.01)


GPS Forecast + Options Trading Strategies   [GPS]  Gap (0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against PSNL



LMB Forecast + Options Trading Strategies   [LMB]  Limbach (-0.74)


FTAI Forecast + Options Trading Strategies   [FTAI]  Fortress Transportation and Infrastructure Investors (-0.76)


SPOK Forecast + Options Trading Strategies   [SPOK]  Spok (-0.77)


ROP Forecast + Options Trading Strategies   [ROP]  Roper (-0.79)


MCK Forecast + Options Trading Strategies   [MCK]  Mckesson (-0.88)